Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Inpharmatica: 3-D bioinformatics

Like many bioinformatics companies, Inpharmatica uses public domain databases to draw comparisons with clients' proprietary sequences. However, instead of simply comparing unknown client sequences with annotated public sequences to predict functionality, Inpharmatica also compares 3-D structure with 3-D structure. This can group proteins by their structure and allows the detection of genes with different sequences but potentially the same function.

The company's approach is based on the

Read the full 663 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers